Key facts
- It has raised $14.0M across 1 recorded rounds; the latest was Early Stage VC ($14.0M) in Dec 2023.
- Notable investors include Shanghai Zhonghuijin Investment Group, Lianyungang Jinhai Venture Capital, Herui Venture Capital, Jiangsu Jinqiao Private Equity Fund Management, Jingbang Capital — 10 tracked in total.
- Status: Privately Held (backing).
Leadership
- Jian Wu (伍建)Co-Founder, Chairman & CEO
- Jingyue JuCo-Founder & Chief Scientist
- Xin Chen (陈鑫)Chief Technology Officer
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Mingyi Intelligent Manufacturing
Funding rounds
1 roundsAbout Mingyi Intelligent Manufacturing
Developer of molecular analysis systems intended for genetic sequencing and diagnostic applications. The company offers microfluidic chip architecture, monochrome fluorescence chemistry, and proprietary enzymatic reagents designed to simplify instrumentation, enhance signal sensitivity, and support full-process automation, serving clinical laboratories and research institutions to perform high-throughput, cost-efficient, and locally deployable genomic testing with improved accuracy and operational scalability.
- Industry
- Biotech
- Sector
- Healthcare
- HQ
- Shenzhen, Guangdong, China
- Founded
- 2018
- Employees
- 12
- Website
- me-itech.com/
- Ownership
- Privately Held (backing)
Mingyi Intelligent Manufacturing doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mingyi Intelligent Manufacturing shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mingyi Intelligent Manufacturing in its N-PORT filings yet. We sweep new filings monthly.